Entelos Secures $6.5M Debt Financing | GenomeWeb
NEW YORK (GenomeWeb News) – Entelos said on Friday that it has signed a debt financing agreement with Imperium Master Fund for a cash loan of $6.5 million.
Entelos said it plans to use $1.5 million of the proceeds to repay debt related to its acquisition of Iconix Biosciences in August. The company will use the remaining $5 million as long-term working capital.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.